Bioventus' Shares Down in Early Trading Amid Higher Q3 Results

MT Newswires Live11-05

Bioventus (BVS) shares fell more than 36% in early trading Tuesday even as the company reported higher Q3 financial results.

The company reported Q3 non-GAAP earnings of $0.06 per share, up from $0.05 a year earlier.

Three analysts polled by Capital IQ expected $0.02.

Net sales for the quarter ended Sept. 28 were $139 million, up from $120.8 million a year earlier.

Three analysts surveyed by Capital IQ expected $133.2 million.

The company said it now expects 2024 non-GAAP EPS of $0.40 to $0.42, compared with its prior guidance of $0.36 to $0.42. Three analysts polled by Capital IQ expect $0.39.

Bioventus said it now expects net sales for the year of $562 million to $567 million, compared with its earlier estimate of $557 million to $567 million. Three analysts surveyed by Capital IQ expect $561.7 million.

Price: 8.77, Change: -4.94, Percent Change: -36.03

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2481688776?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-05 22:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2481688776","market":"hk","top_or_hot":-1,"title":"Bioventus' Shares Down in Early Trading Amid Higher Q3 Results","media":"MT Newswires Live","content":"<html><body><p> Bioventus (BVS) shares fell more than 36% in early trading Tuesday even as the company reported higher Q3 financial results.</p><p>The company reported Q3 non-GAAP earnings of $0.06 per share, up from $0.05 a year earlier.</p><p>Three analysts polled by Capital IQ expected $0.02.</p><p>Net sales for the quarter ended Sept. 28 were $139 million, up from $120.8 million a year earlier.</p><p>Three analysts surveyed by Capital IQ expected $133.2 million.</p><p>The company said it now expects 2024 non-GAAP EPS of $0.40 to $0.42, compared with its prior guidance of $0.36 to $0.42. Three analysts polled by Capital IQ expect $0.39.</p><p>Bioventus said it now expects net sales for the year of $562 million to $567 million, compared with its earlier estimate of $557 million to $567 million. Three analysts surveyed by Capital IQ expect $561.7 million.</p><p>Price: 8.77, Change: -4.94, Percent Change: -36.03</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bioventus' Shares Down in Early Trading Amid Higher Q3 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioventus' Shares Down in Early Trading Amid Higher Q3 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-05 22:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Bioventus (BVS) shares fell more than 36% in early trading Tuesday even as the company reported higher Q3 financial results.The company reported Q3 non-GAAP earnings of $0.06 per share, up from $0.05 ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BVS","symbol_name":"Bioventus Inc.","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2481688776","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2481688776","pubTimestamp":1730818241,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Bioventus  shares fell more than 36% in early trading Tuesday even as the company reported higher Q3 financial results.The company reported Q3 non-GAAP earnings of $0.06 per share, up from $0.05 a year earlier.Three analysts polled by Capital IQ expected $0.02.Net sales for the quarter ended Sept. 28 were $139 million, up from $120.8 million a year earlier.Three analysts surveyed by Capital IQ expected $133.2 million.The company said it now expects 2024 non-GAAP EPS of $0.40 to $0.42, compared with its prior guidance of $0.36 to $0.42. Three analysts polled by Capital IQ expect $0.39.Bioventus said it now expects net sales for the year of $562 million to $567 million, compared with its earlier estimate of $557 million to $567 million. Three analysts surveyed by Capital IQ expect $561.7 million.Price: 8.77, Change: -4.94, Percent Change: -36.03","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BVS":"Bioventus Inc.","BK4108":"电影和娱乐","BK4505":"高瓴资本持仓","BK7016":"应用软件","BK4526":"热门中概股","BK4198":"医疗保健用品","BK4552":"Archegos爆仓风波概念","BVS.AU":"BRAVURA SOLUTIONS LTD","BK7503":"科技股","BK4531":"中概回港概念"},"translate_title":"由于第三季度业绩走高，Bioventus股价早盘下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BVS":1,"BVS.AU":1},"content_text":"Bioventus (BVS) shares fell more than 36% in early trading Tuesday even as the company reported higher Q3 financial results.The company reported Q3 non-GAAP earnings of $0.06 per share, up from $0.05 a year earlier.Three analysts polled by Capital IQ expected $0.02.Net sales for the quarter ended Sept. 28 were $139 million, up from $120.8 million a year earlier.Three analysts surveyed by Capital IQ expected $133.2 million.The company said it now expects 2024 non-GAAP EPS of $0.40 to $0.42, compared with its prior guidance of $0.36 to $0.42. Three analysts polled by Capital IQ expect $0.39.Bioventus said it now expects net sales for the year of $562 million to $567 million, compared with its earlier estimate of $557 million to $567 million. Three analysts surveyed by Capital IQ expect $561.7 million.Price: 8.77, Change: -4.94, Percent Change: -36.03","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2481688776"}